Monoclonal proteins after stem cell transplant may predict survival

08/26/2013 | MyelomaBeacon.com

Multiple myeloma patients whose monoclonal protein levels were declining 100 days after autologous stem cell trans­planta­tion survived longer overall and without disease progression, Mayo Clinic researchers found. The presence of lgG-type M proteins and myeloma cell levels of 3% or lower were linked with future continued response, according to the retrospective analysis in the journal Blood.

View Full Article in:

MyelomaBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC